Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140295 · ClinicalTrials.gov registry record · Phase 4
Bowel Preparation for Colonoscopy in Children
A Phase 4 study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT01140295 is a Phase 4 study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 33 participants.
The verdict
NCT01140295, a Phase 4 study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether Miralax results in a more efficacious preparation as compared to senna for pediatric colonoscopy.
Interventions
- DRUG polyethylene glycol, senna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01140295
The ClinicalTrials.gov registry entry for NCT01140295 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which polyethylene glycol, senna is the first listed.
NCT01140295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01140295 about?
NCT01140295 is a clinical study titled "Bowel Preparation for Colonoscopy in Children". The primary objective of this study is to determine whether Miralax results in a more efficacious preparation as compared to senna for pediatric colonoscopy.
What is the current status of trial NCT01140295?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2010-09. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01140295?
The interventions under investigation include: polyethylene glycol, senna (DRUG).
Who is sponsoring clinical trial NCT01140295?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.